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Abstract
Background: Echocardiography is a key investigation in the management of patients
on extracorporeal membrane oxygenation (ECMO). However, echocardiographic
images are often non-diagnostic in this patient population. Contrast-enhanced
echocardiography may overcome many of these limitations but contrast microspheres
are hydrodynamically labile structures prone to destruction from shear forces and
turbulent flow, which may exist within an ECMO circuit. This study sought to evaluate
microsphere destruction (utilising signal intensity as a marker of contrast concentration)
during transit through an ECMO circuit.
Methods: Activated Definity® contrast was diluted to 50 ml with normal saline and
infused into a crystalloid primed ex vivo ECMO with a Quadrox oxygenator at 150 ml/h.
Imaging was performed on pre- and post-pump head/oxygenator sections of the circuit
using a Philips iE33 scanner and S5-1 transducer. Five-millimetre regions of interest were
placed in the centre of the ultrasound field. Average signal intensity (decibels) was
calculated at speeds of 1000, 2000, 3000 and 4000 rpm and then repeated with an
infusion rate of 300 ml/h. The oxygenator was then spliced out of the circuit and
the measures repeated.
Results: There was a significant reduction in contrast concentration during passage
through the ECMO circuit at all speeds (with higher pump head speeds resulting in
greater microsphere destruction). In a circuit with an oxygenator, relative decrease
in signal intensity was 21.4 versus 5.2 % without an oxygenator. There was significant
destruction of contrast microspheres during passage through the ECMO circuit at all
pump head speeds. An oxygenator contributed to microsphere destruction at a
significantly greater level than the pump head alone. There was no significant difference
in mean signal intensity reduction in the circuit between an infusion of 150 or 300 ml/h
(3.5 ± 3.2 versus 3.6 ± 2.5 dB, respectively, p = 0.79).
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Conclusions: Flow of contrast through an ECMO circuit results in significant destruction
of microspheres. Circuits with an oxygenator result in significantly greater levels of
contrast destruction than by the pump head alone. Clinicians should be cognisant
of the relationship between ECMO circuit configurations, pump head speed and
contrast destruction when performing a contrast-enhanced echocardiogram in
patients supported with ECMO.
Keywords: Extracorporeal membrane oxygenation, Contrast echocardiography,
Oxygenator
Background
Extracorporeal membrane oxygenation (ECMO) is a modified form of cardiopulmonary
bypass used to provide cardiac and/or respiratory support in patients that have not
responded to maximal medical support [1–5]. The use of ECMO is increasing [6], and
echocardiography plays a fundamental role throughout the care of a patient supported
on ECMO [7, 8]. However, provision of ECMO usually takes place within a critical care
complex and assessment of these patients using transthoracic echocardiography can be
challenging due to sub-optimal image quality in up to 25 % of patients. Reasons for this
include the inability to position the patient to optimise acoustic windows, sub-optimal
lighting conditions, invasive ventilation and the presence of surgical drains or sites lim-
iting scanning planes. The administration of a contrast agent during echocardiography
can help minimise these non-diagnostic echocardiograms [9–11].
However, these contrast microspheres are hydrodynamically labile structures and are
prone to destruction from shear forces and turbulent flow, which exist within an
ECMO circuit. This destruction within an ECMO circuit has never been confirmed nor
quantified. Reduced contrast concentration due to microbubble destruction would alter
ultrasound backscatter signal intensity and hence may affect ultrasound image quality
and reduce accuracy of the test. The aim of this study was to quantify the degree of
microsphere destruction, utilising signal intensity as a marker of contrast concentra-
tion, during transit through an ex vivo ECMO circuit using quantitative echocardiog-
raphy. A secondary aim was to assess the impact of an oxygenator on bubble
destruction within an ECMO circuit.
Methods
An ex vivo ECMO circuit was primed and operated at multiple pump head speeds. An
echocardiographic contrast agent was administered via an infusion, and echocardio-
graphic images were obtained pre- and post-pump head to assess signal intensity, used
as a surrogate marker for contrast concentration.
ECMO circuit
The ECMO circuit consisted of a bioline-coated Quadrox PLS oxygenator plus RF32
Rotaflow centrifugal pump head connected to a Rotaflow drive console (Maquet Cardio-
pulmonary AG, Hirrlingen, Germany) with no reservoir. The circuit was primed with
0.9 % sodium chloride (Baxter Healthcare Pty Ltd, Toongabbie, NSW, Australia), 30 ml of
8.4 % sodium bicarbonate (Pfizer Australia, West Ryde, NSW, Australia) and warmed to
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37 °C. The oxygenator was filled with room air (FiO2 of 21 %). Sideport tubing provided
access for administration of the contrast agent prior to the pump head. The ECMO circuit
was run at four pump head speeds: 1000, 2000, 3000 and 4000 rpm, during an infusion of
an echocardiographic contrast agent. Figure 1 is a schematic of the circuit design (arrows
indicate direction of flow).
Contrast agent
Definity® (Lantheus Medical Imaging, Billerica, MA, USA) contrast agent is a perflutren
microsphere with a mean diameter of 1.1–3.3 μm. It consists of a central core of octo-
fluoropropane gas, a high molecular weight (188), biologically inert gas and a tri-lipid
outer shell [12]. The inactivated ampoule of Definity contrast consists of the clear li-
quid lipid shell below and the gaseous core above. It requires activation in a VialMix®
device, which agitates the ampoule at 4530 ± 100 oscillations per minute for 45 s. This
generates a solution of perflutren microsphere bubbles, which have an opaque, milky
white appearance. Activation results in 1.3 ml of contrast. The activated contrast was
then diluted to 50 ml with normal saline and infused using an Alaris® GH Plus (CareFu-
sion, San Diego, CA, USA) infusion pump. Contrast was infused at two different rates,
150 and 300 ml/h. These rates were selected because 150 ml/h is the typical starting
rate for a 50-ml dilution and 300 ml/h is a typical infusion rate for technically difficult
patients in the critical care complex.
Image acquisition and analysis
A 5-millimetre (mm)-thick silicon ultrasound stand-off was placed between the ultrasound
transducer and ECMO circuit tubing. A S5-1 ultrasound transducer and Philips iE33 ultra-
sound scanner were used for image acquisition. Contrast-specific imaging was activated,
utilising low mechanical index and power modulation imaging. The scanning settings were
Fig. 1 Schematic diagram of the ECMO circuit, with arrows indicating direction of flow
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constant for all acquired images: transducer frequency of 2 MHz, gain of 40 %, compression
at 50, depth of field of 5 cm, frame rate of 39 Hz and a mechanical index of 0.1. Following
an infusion of contrast for 2 min, 2-s ultrasound clips were then acquired at two separate
sites within the ECMO circuit. As such, each data point consisted of 78 ultrasound frames
for analysis. Two-second ultrasound clips were then acquired at two sites within the ECMO
circuit following an infusion of Definity contrast. The first site (labelled ‘pre-circuit’) was
located 10 cm after the site of entry of contrast into the circuit but before the pump head.
The second site (labelled ‘post-circuit’) was located at the end of the circuit and 10 cm
before the site of entry of contrast into the circuit.
Contrast images were acquired at the four different pump head speeds (1000, 2000,
3000 and 4000 rpm), during an infusion of contrast at 150 ml/h. This was then re-
peated at a contrast infusion rate of 300 ml/h. Following acquisition of these images,
the oxygenator was removed from the circuit and contrast was re-infused into the cir-
cuit. A repeat set of images were acquired at the four pump head speeds (1000–4000)
and at the two different infusion rates (150 and 300 ml/h).
The images were transferred to a separate workstation and analysed using QLAB
quantification software (Philips Medical Systems, Amsterdam, Netherlands). A pre-set
5-mm square region of interest (ROI) was placed in the centre of the acquired ultra-
sound image. The mean signal intensity (measured in decibels) was calculated over this
2-s clip. The mean signal intensity over this time interval was used as a surrogate of
microbubble contrast concentration. Figure 2 is an example of a contrast signal inten-
sity graph (measured in decibels) over 2 s with a central 5 mm2 region of interest.
Statistical analysis
Contrast signal intensity for each view, pre and post, the ECMO circuit was expressed
as mean ± one standard deviation. Comparison between the continuous variables was
Fig. 2 Example of a contrast signal intensity graph (measured in decibels) over 2 s with a central 5 mm2
region of interest
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performed using the paired Student’s t test for pre- versus post-circuit analysis and un-
paired Student’s t test for full circuit versus no oxygenator comparison. A p value of
<0.05 was considered as statistically significant. Statistical analysis was performed using
MedCalc version 10.0 (Mariakerke, Belgium).
Results
Echocardiographic imaging was technically feasible at both locations (pre-circuit and
post-circuit) at all ECMO speeds. There was a significant reduction in contrast concen-
tration during passage through the ECMO circuit at all speeds. The mean signal inten-
sities ± 1 standard deviation (measured in decibels) pre- and post-circuit for the
combined speed data (full circuit and no oxygenator in the circuit) are displayed in
Table 1. There was a significant reduction in signal intensity (mean of 5.4 dB) for com-
bined data in a full circuit (from 25.3 ± 1.9 to 19.9 ± 2.6, p < 0.0001). There was a
smaller but still significant reduction in signal intensity (mean of 1.6 dB) for combined
data in a circuit with no oxygenator (from 30.8 ± 2.4 to 29.2 ± 2.0, p < 0.0001). In a cir-
cuit with an oxygenator, the relative decrease in signal intensity was 21.4 %, whilst in a
circuit with no oxygenator, the relative decrease in signal intensity was 5.2 %. There
was no significant difference in mean signal intensity variation in the circuit between
an infusion of 150 or 300 ml/h (3.5 ± 3.2 versus 3.6 ± 2.5 dB, respectively, p = 0.79).
The mean difference in signal intensity between a circuit with and without an oxy-
genator is displayed in Fig. 3. The mean difference in signal intensity at the four pump
head speeds and two infusion rates in circuits with and without an oxygenator is dis-
played in Table 2. At all pump head speeds, there was significantly greater microbubble
destruction in an ECMO circuit with an oxygenator, compared to a circuit without an
oxygenator. Mean difference in signal intensity for combined data (circuits with and
without an oxygenator and at both infusion rates) at all four pump head speeds is dis-
played in Fig. 4. Figure 5a, b demonstrates examples of pre-circuit and post-circuit con-
trast echocardiographic images, respectively. Additional file 1: Video 1 and Additional
file 2: Video 2 are the corresponding 2-s acquired clips.
Discussion
Echocardiography is an important investigation in patients supported with ECMO.
Transthoracic echocardiography is typically the first line cardiac imaging investigation
in these patients [13]. However, up to 25 % of transthoracic echocardiograms may be
non-diagnostic due to adverse ultrasound scanning conditions. These include patients
being immobile, supine and attached to a ventilator, issues with accessing suitable
Table 1 Mean signal intensities (measured in decibels) pre- and post-circuit for the combined
speed data (with and without an oxygenator in the circuit)
Pre-circuit (dB) Post-circuit (dB) Difference p value
Oxygenator 150 ml/h 24.6 ± 1.7 18.9 ± 2.4 5.7 ± 3.0 p < 0.0001
Oxygenator 300 ml/h 25.9 ± 1.9 20.8 ± 2.6 5.1 ± 2.1 p < 0.0001
Oxygenator combined 25.3 ± 1.9 19.9 ± 2.6 5.4 ± 2.6 p < 0.0001
No oxygenator 150 ml/h 30.9 ± 1.3 29.6 ± 1.4 1.3 ± 1.5 p < 0.0001
No oxygenator 300 ml/h 30.6 ± 3.1 28.8 ± 2.5 1.8 ± 1.8 p < 0.0001
No oxygenator combined 30.8 ± 2.4 29.2 ± 2.0 1.6 ± 1.7 p < 0.0001
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acoustic windows and sub-optimal lighting conditions [14, 15]. Contrast-specific echo-
cardiographic imaging modalities can help overcome these limitations and increase the
diagnostic yield of echocardiography. However, echocardiographic contrast agents are
hydrodynamically labile microspheres and likely to be prone to destruction within an
ECMO circuit. There are multiple factors which can influence contrast microsphere
stability, including the insonicating ultrasound power (mechanical index), ambient
temperature, sheer forces and also the particle pressure of gases [16]. These contrast
microspheres are likely to be prone to destruction within an ECMO circuit. In our
research, this was demonstrated by a decrease in microbubble concentration at both in-
fusion rates, with and without an oxygenator in situ and at all pump head speeds.
Fig. 3 The mean difference in signal intensity (decibels) between a circuit with and without an oxygenator
(combined data)
Table 2 Mean difference in signal intensity (measured in decibels) at the four pump head speeds
and two infusion rates in circuits with and without an oxygenator
Mean difference (dB) Mean difference (dB) p value
1000 rpm oxygenator
150 ml/h
4.2 ± 2.6 1000 rpm no oxygenator
150 ml/h
1.4 ± 1.3 p < 0.0001
2000 rpm oxygenator
150 ml/h
4.5 ± 2.1 2000 rpm no oxygenator
150 ml/h
0.6 ± 1.6 p < 0.0001
3000 rpm oxygenator
150 ml/h
7.1 ± 2.4 3000 rpm no oxygenator
150 ml/h
0.7 ± 1.0 p < 0.0001
4000 rpm oxygenator
150 ml/h
6.7 ± 2.5 4000 rpm no oxygenator
150 ml/h
2.5 ± 1.0 p < 0.0001
1000 rpm oxygenator
300 ml/h
5.9 ± 2.7 1000 rpm no oxygenator
300 ml/h
0.6 ± 2.3 p < 0.0001
2000 rpm oxygenator
300 ml/h
3.9 ± 2.0 2000 rpm no oxygenator
300 ml/h
2.5 ± 1.6 p < 0.0001
3000 rpm oxygenator
300 ml/h
4.6 ± 1.4 3000 rpm no oxygenator
300 ml/h
1.6 ± 1.1 p < 0.0001
4000 rpm oxygenator
300 ml/h
6.1 ± 1.5 4000 rpm no oxygenator
300 ml/h
2.9 ± 0.7 p < 0.0001
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Despite the statistically significant decrease in signal intensity through the circuit with-
out an oxygenator, the smaller magnitude of drop suggests that the oxygenator contrib-
utes to a significantly greater degree of bubble destruction than in the pump head
alone (75 versus 25 %, respectively). To our knowledge, this is the first study to evaluate
the site and quantify the degree of contrast microbubble destruction within an ECMO
circuit.
An ECMO circuit in clinical use consists of access and return cannulae, biocompat-
ible tubing to transport the blood between the patient and ECMO pump, a controller
to adjust flows, a blood warmer and an oxygenator for gas exchange [1]. There are
three likely sites of contrast microbubble destruction within an ECMO circuit: the
access and return points, the pump head and finally, the oxygenator. The access and
return points usually consist of large bore cannulae, of which there are numerous
designs [17]. The flow within the main body of these cannulae is laminar. At the points
of blood entering the ECMO circuit at the tip of the access cannula and blood exiting
Fig. 4 Mean difference (combined data) in signal intensity across the ECMO circuit at different pump head
speeds (1000–4000 rpm). ns not significant
Fig. 5 a, b Pre-ECMO and post-ECMO contrast echocardiographic images. Note the reduced signal intensity
in the post-ECMO image
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the circuit in the return cannula, the flow would transform from laminar to turbulent.
This turbulent flow would have an impact on microsphere destruction. Flow is also tur-
bulent at the edge of the blood pool and adjacent to the inner surface of the cannulae
or tubing. This is termed boundary layer turbulence [17]. Along the whole length of
the ECMO circuit tubing (not only just the cannulae), this boundary layer turbulence
will exist and also contribute to the destruction of the contrast microbubbles. However,
the degree of turbulence here is likely to be significantly less than in the pump head.
Contrast microbubble destruction is more likely to occur at the pump head and the
oxygenator. At these sites, there is very high velocity flow, significant pressure differen-
tials and non-laminar, turbulent flow, all of which increase the shear stress on micro-
bubbles. The pump head used in this ECMO circuit was a Rotaflow centrifugal pump.
This has a mechanical, low-friction bearing point and is magnetically rotated. The
priming volume is 32 ml, the surface area is only 0.19 cm2 and the rotor diameter is
50 mm and is constructed with polycarbonate [18]. The internal rotor spins at a rate
which can be adjusted on the external controller, with spin rates in the clinical environ-
ment often in the range of 2500–5000 rpm. This spinning generates a constrained vor-
tex and hence a pressure differential across the pump head [19].
Contrast microsphere destruction may occur within the pump head due to several
factors. Direct contact with a rapidly rotating mechanical structure within the pump
head is likely to lead to microbubble destruction. Additionally, the non-physiologic and
rapid centrifugal flow within the pump head is likely to directly contribute to micro-
bubble destruction. The high pressure drop across the pump head would contribute to
increased destructive shear forces. In this research, there was a statistically significant
decrease in microbubble concentration across the pump head, with the most likely
mechanism being destruction from shear forces and the turbulent flow. With increas-
ing pump head speeds, there was an increase in microsphere destruction (except for
the increment from 1000 to 2000 rpm). With higher spin rates, the destructive forces
within the rotor housing would be higher (especially due to increased flow turbulence
and greater pressure differentials) and this would result in a greater degree of micro-
sphere destruction within the pump head. Whist one could anticipate a linear correl-
ation between microsphere destruction and all pump head speeds, it could be
postulated that the absolute destructive forces at these lower pump head speeds
(1000 to 2000 rpm) may not be sufficiently different to be translated into a signifi-
cant difference in microsphere destruction at this lower revolutions per minute in-
crement. Unexpectedly, however, the degree of microbubble destruction caused by
the pump head was significantly less than that caused by the oxygenator.
Oxygenators are used within standard cardiopulmonary bypass machines and within
ECMO circuits. They are one of the key components within an extracorporeal support
circuit. Oxygenators have the dual purpose of enabling gas exchange and providing
thermoregulation of the blood [20, 21]. Contemporary ECMO oxygenators can be clas-
sified as silicone membrane oxygenators, microporous hollow fibre oxygenators and
true membrane hollow fibre oxygenators [22]. The commonest type currently used in
ECMO, including the Quadrox PLS, is a true membrane hollow fibre oxygenator. These
oxygenators consist of mats of hollow fibres constructed of polymethylpentene. The
fibres are laid out in parallel mats which are then interposed repeatedly. This is demon-
strated in Fig. 6. The priming volume of the Quadrox PLS oxygenator is 250 ml, with
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blood flow tolerance of between 0.5 and 7.0 l/min. The effective surface area for gas
exchange is 1.8 m2 [18]. Figure 7a shows the Quadrox PLS oxygenator, and Fig. 7b
demonstrates the polymethylpentene fibre mats within the oxygenator.
In this research, there was a significantly greater level of contrast microsphere de-
struction in a circuit with an oxygenator. This implies that the oxygenator played an
important role in contrast destruction within an ECMO circuit. Despite the presence of
significant microbubble destruction during passage through an ECMO circuit, there
was still a strong backscatter signal from residual contrast, even with an oxygenator in
situ. This suggests that contrast-enhanced transthoracic echocardiography would most
likely be technically feasible in this patient population, with adjustment of the infusion
rate to achieve an optimal contrast-enhanced image. As there was no significant differ-
ence in mean signal reduction across the circuits between the two infusion rates, this
Fig. 6 Quadrox oxygenator during construction. Note the multiple layers of hollow fibre mats interposed
repeatedly. Image reproduced with permission (Maquet Cardiopulmonary AG, Germany)
Fig. 7 a The Quadrox PLS oxygenator and b the polymethylpentene fibre mats within the oxygenator
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suggests that infusion rate does not have a significant impact on the degree of bubble
destruction within the ECMO circuit, though it may impact baseline image quality.
Consequently, the clinician can adjust the baseline infusion rate with the knowledge
that higher infusion rates would not cause relatively greater degrees of bubble destruc-
tion, which may then adversely affect image quality. Contrast-enhanced echocardiog-
raphy has been shown to be possible in an ovine model of ECMO and, in the clinical
setting, with an oxygenator in the circuit [23–25].
One important parameter affecting shear stress is the pressure drop across a struc-
ture. At peak flows, the pressure drop across an ECMO pump head can be as high as
900 mmHg. However, at maximal flows, the pressure drop across an oxygenator is
much lower, approximately 75 mmHg. This would imply that the shear forces gener-
ated within the pump head would contribute to a greater degree of bubble destruction
than within the oxygenator.
However, the results of this study showed that there was a significant difference (in-
crease) in microbubble destruction between a full circuit (with an oxygenator) versus a
circuit with no oxygenator, and this occurred at all pump head speeds. This suggested
that the presence of an oxygenator was a more important predictor of microbubble
destruction than the actual pump head speed. There are several mechanisms that may
explain this unexpected increase in microbubble destruction with the oxygenator in
situ. Firstly, between the entry and exit points of an oxygenator, the flow path may be
complex and involve numerous acute changes in direction, with repeated contact
against the rigid polymethylpentene fibres. This could increase the shear stress on
microbubbles and hence promote destruction. As the oxygenator is designed to maxi-
mise mass transfer within a relatively small and confined space, the repeatedly inter-
posed fibre mats would act as recurrent sites for microbubble trauma.
Alternative mechanisms for oxygenator-induced microsphere destruction may not
directly involve shear forces but be related to the function of gas trapping and hydro-
phobic interactions. Other than gas transfer, oxygenators also provide a gas/air trapping
protective function. The inlet and outlet points of an oxygenator are specifically at its
base to enable any air within the circuit, which would ‘rise’, to be removed via the outlet
at the top of the oxygenator and hence eradicated from the circuit. Whilst the com-
parative buoyancy properties of Definity® microspheres in normal saline versus blood
are not known, these microspheres are buoyant and will rise to the surface in a liquid
[26]. As such, it is conceivable that some of the delivered contrast agent is gas trapped
within the oxygenator, in a similar way that air bubbles would be trapped.
Hydrophobic interactions between the contrast microsphere and hollow fibre mem-
branes within an oxygenator (and other components within an ECMO circuit) may also
contribute to microsphere destruction. These hydrophobic interactions have been
shown to be of importance during ECMO pharmacokinetic studies, where up to 90 %
of some drugs may be removed by the circuit [27, 28]. Common reasons for drug
pharmacokinetics being influenced by ECMO in vivo include circuit sequestration,
increased volume of distribution, and decreased drug elimination [29]. Whilst not all of
these are relevant to our ex vivo circuit, contrast microspheres are hydrophobic but not
lipophilic. As such, direct interactions between these hydrophobic microspheres and
the hydrophobic polymethylpentene hollow fibres may also result in trapping of the
microspheres within the oxygenator.
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Study limitations
This study was performed in an ex vivo ECMO circuit where the differential de-
struction of the pump head and oxygenator were assessed in controlled laboratory
conditions. Whilst the circuit equipment is the same as used clinically, there are
numerous important differences. The main difference was that there was no patient
component that would contribute to microbubble destruction. Also, in light of this,
there were no access or return cannulae located within the ex vivo circuit. Flow
through these cannulae also contributes to microbubble destruction. There are nu-
merous sites for contrast microbubble destruction in the ECMO circuit, including
the conduit tubing. This research focussed on the oxygenator and pump head com-
ponents. It was not possible to isolate the relative contribution of boundary turbu-
lent flow related to this tubing, which is an important component of an ECMO
circuit. Also, whilst unlikely to be clinically relevant to microbubble destruction,
this ex vivo circuit was primed with normal saline, which has a viscosity approxi-
mately one third that of blood. Ideally, blood would have been the preferable prod-
uct to prime the ECMO circuit. However, the constraints of our research resulted
in access to saline for the circuit priming. However, the results may be still mean-
ingful as there were significant identifiable differences in the contrast concentra-
tions between the two circuits, and as saline was used in both circuits, it would
not have accounted for this difference in signal intensity.
The signal intensity measured within the 5-mm2 ROI was a mean of 78 values over
2 s (as these contrast-specific images were acquired at a frame rate of 39 Hz) which
varied around this mean. The signal intensity was not constant over these 2 s clips
within this ROI despite a constant infusion. This slight signal intensity variation would
be most likely due to the rapid flow of contrast microbubbles mixed through the larger
volume of 0.9 % sodium chloride priming solution traversing the ECMO circuit tubing.
This is demonstrated in Additional file 1: Video 1 and Additional file 2: Video 2. Whilst
contrast microspheres have a short half-life, the circuit was not flushed and re-primed
after removal of the oxygenator. As such, there may have been a small quantity of re-
sidual contrast within the circuit for the commencement of the second circuit. How-
ever, it was felt this would not have a significant effect due to the high concentration
following reinfusion and the assessment of relative contrast destruction across the cir-
cuit. Finally, this research analysed one type of ECMO circuitry (Quadrox PLS Oxygen-
ator and Rotaflow pump head). Other ECMO circuitry components are available, and
our results would not be interchangeable with other circuits.
Conclusions
There was a significant decrease in contrast microsphere concentration during the pas-
sage through an ex vivo ECMO circuit. This phenomenon occurred regardless of pump
head speed, but higher pump head speeds resulted in greater microsphere destruction.
The presence of an oxygenator within the ECMO circuit contributed to microsphere
destruction at a significantly greater level than the pump head alone. Translation to the
bedside suggests that clinicians should be cognisant of the relationship between ECMO
circuit configurations, pump head speed and contrast destruction when performing
contrast-enhanced transthoracic echocardiography.
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Additional files
Additional file 1: Video 1. Two second movie clip of the ECMO circuit pre-pump at 4000 RPM. (AVI 2000 kb)
Additional file 2: Video 2. Two second movie clip of the ECMO circuit post-pump at 4000 RPM. (AVI 2000 kb)
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